Convergence Investment Partners’s Eagle Pharmaceuticals, Inc. EGRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2019
Q4 | – | Sell |
-2,699
| Closed | -$153K | – | 326 |
|
|
2019
Q3 | $153K | Sell |
2,699
-1,883
| -41% | -$107K | 0.04% | 249 |
|
|
2019
Q2 | $255K | Buy |
+4,582
| New | +$255K | 0.06% | 215 |
|
|
2017
Q3 | – | Sell |
-14,962
| Closed | -$1.18M | – | 405 |
|
|
2017
Q2 | $1.18M | Buy |
14,962
+7,980
| +114% | +$629K | 0.17% | 224 |
|
|
2017
Q1 | $579K | Buy |
+6,982
| New | +$579K | 0.08% | 293 |
|